Leuprolide and pleural effusion Patient Reports February 12, 2012

Leuprolide Side Effects Report #5949184-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 05, 2008. Male patient, 92 years of age, was diagnosed with prostate cancer stage iv, pneumonia , dehydration, hepatic function abnormal and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: malignant pleural effusion, prostate cancer . Leuprolide dosage: unknown. During the same period patient was treated with CEFOTIAM HYDROCHLORIDE, BICALUTAMIDE, ESTRAMUSTINE PHOSPHATE, DEXAMETHASONE, MALTOSE, GLUTATHIONE, STRONG NEO MINOPHAGEN C. Patient died on 12/21/2007.

Leuprolide Side Effects Report #5963936-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 16, 2008. Male patient, 92 years of age, weighting 111.1 lb, was diagnosed with prostate cancer stage iv, pneumonia , dehydration, hepatic function abnormal and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: malignant pleural effusion, prostate cancer . Leuprolide dosage: unknown. During the same period patient was treated with CEFOTIAM HYDROCHLORIDE, BICALUTAMIDE, ESTRAMUSTINE PHOSPHATE, DEXAMETHASONE, MALTOSE, GLUTATHIONE, STRONG NEO MINOPHAGEN C. Patient died on 12/21/2007.

Leuprolide Side Effects Report #5989095-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 25, 2008. Male patient, 92 years of age, weighting 111.1 lb, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dehydration, hepatic function abnormal, malignant pleural effusion, prostate cancer . Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, ESTRAMUSTINE PHOSPHATE, DEXAMETHASONE. Patient died on 12/21/2007.

Leuprolide Side Effects Report #5852693-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2008. Male patient, 85 years of age, was diagnosed with prostate cancer stage iv, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: pleural effusion. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, BICALUTAMIDE, NAFTOPIDIL, FLAVOXATE. Patient died on 07/10/2007.


Leuprolide Side Effects Report #5451818-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 07, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, arrhythmia , cardiac failure congestive, haemodialysis, pleural effusion, renal failure acute, respiratory tract infection. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, ARTIST, ALDACTONE, ACECOL, OMEPRAL, NU LOTAN, FERROMIA, PURSENNID. Patient recovered.

Leuprolide Side Effects Report #5878036-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv, benign prostatic hyperplasia, neurogenic bladder and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: nasopharyngitis, pleural effusion, pneumonia . Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, NAFTOPIDIL, DISTIGMINE BROMIDE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5979407-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 25, 2008. Male patient, 90 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: marasmus, pleural effusion. Leuprolide dosage: unknown. Patient died on 12/13/2007.

Leuprolide Side Effects Report #6004348-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 08, 2008. Male patient, 90 years of age, weighting 121.3 lb, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: marasmus, pleural effusion. Leuprolide dosage: unknown. Patient died on 12/13/2007.

Leuprolide Side Effects Report #5407674-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 01, 2007. Male patient, 78 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, metastases to bone, pleural effusion. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, TAMSULOSIN. Patient died.


Leuprolide Side Effects Report #5578472-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: bacterial infection , interstitial lung disease, myocardial ischaemia, pleural effusion, respiratory failure, sputum culture positive, staphylococcal infection . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with NORVASC, PREDINONE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5819088-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Male patient, 75 years of age, was diagnosed with prostate cancer stage i, constipation , diabetes mellitus and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: mesothelioma malignant, pleural effusion. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, PURSENNID, NOVOLIN R. Patient was hospitalized. Patient died on 04/17/2007.

Leuprolide Side Effects Report #5871644-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Male patient, 75 years of age, was diagnosed with prostate cancer stage i, constipation , diabetes mellitus and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: mesothelioma malignant, pleural effusion. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, PURSENNID, NOVOLIN R. Patient was hospitalized. Patient died on 04/17/2007.

Leuprolide Side Effects Report #5165521-5
Leuprolide side effect was reported by a Physician from JAPAN on Nov 22, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: haemoptysis, interstitial lung disease, no therapeutic response, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, RESTREAM, EVIPROSTAT, ALESION, ZANTAC, LAXOBERON. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4978986-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 31, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: ascites, calcinosis, cholelithiasis, hepatic cyst, lymphadenopathy, pancreatitis, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, URSO, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.


Leuprolide Side Effects Report #5046833-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, dyspnoea, haemoptysis, interstitial lung disease, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX, RESTREAM, EVIPROSTAT, ALESION, ZANTAC, LAXOBERON. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4996462-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 12, 2006. Male patient, 74 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac arrest , interstitial lung disease, metastases to lung, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS - SEE IMAGE. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CHLORMADINONE ACETATE, HONVAN, CASODEX. Patient died.

Leuprolide Side Effects Report #5179016-6
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on Dec 05, 2006. Female patient, 38 years of age, was diagnosed with in vitro fertilisation and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: ascites, dyspnoea, pleural effusion. Leuprolide dosage: 1.87 MG (1.87 MG, 1 IN 1 DOSE). During the same period patient was treated with GONAL, GONADOTROPHIN CHRORIONIC, UTROGESTAN. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5197697-8
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on Dec 22, 2006. Female patient, 38 years of age, was diagnosed with in vitro fertilisation and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: ascites, dyspnoea, ovarian hyperstimulation syndrome, pleural effusion. Leuprolide dosage: 1.87 MG (1.87 MG, 1 IN 1 ONCE), SUBCUTANEOUS/DAYS. During the same period patient was treated with GONAL, GONADOTROPHIN CHRORIONIC, UTROGESTAN. Patient recovered.